Keyphrases
Trabecular Meshwork Cells
100%
Phospholipase C
100%
Endothelin-1 (ET-1)
100%
Guanylate Cyclase
100%
Receptor Subtypes
37%
ETA Receptor
37%
Sarafotoxins
37%
ETB Receptor
25%
EC50
25%
Receptor Antagonist
12%
Cyclic Adenosine Monophosphate (cAMP)
12%
Dose Effect
12%
Inositol Phosphate
12%
Human Trabecular Meshwork
12%
Selective Antagonist
12%
High Concentration
12%
Concentration-dependent
12%
Cell Lysate
12%
Cyclic GMP
12%
Phospholipase C Activity
12%
Radioimmunoassay
12%
BQ-788
12%
Receptor Agonist
12%
Adenylyl Cyclase Activity
12%
Subtype-specific
12%
Simian Virus 40 (SV40)
12%
IOP-lowering Effect
12%
Pre-treating
12%
Subtype-selective Agonist
12%
Nucleotide Cyclase
12%
Cyclic GMP-AMP
12%
BQ123
12%
Pharmacology, Toxicology and Pharmaceutical Science
Endothelin
100%
Guanylate Cyclase
100%
Lecithinase
100%
Endothelin 1
85%
Receptor Subtype
42%
Sarafotoxin S6c
42%
Cyclic GMP
28%
EC50
28%
Receptor
14%
Inositol Phosphate
14%
Cyclic AMP
14%
Adenylate Cyclase
14%
Radioimmunoassay
14%
Receptor Agonist
14%
Simian Virus 40
14%
Receptor Antagonist
14%
Biochemistry, Genetics and Molecular Biology
Guanylate Cyclase
100%
Endothelin
100%
Lecithinase
100%
Endothelin 1
85%
Cyclic Guanosine Monophosphate
28%
EC50
28%
Receptor Antagonist
14%
Agonist
14%
Cyclic Adenosine Monophosphate
14%
Cell Lysate
14%
Receptor Agonists
14%
Adenylate Cyclase
14%
Simian Virus 40
14%
Cyclase
14%
BQ-123
14%
Inositol Phosphate
14%